Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.
- Market Cap ₹ 8,596 Cr.
- Current Price ₹ 695
- High / Low ₹ 748 / 267
- Stock P/E 102
- Book Value ₹ 22.0
- Dividend Yield 0.12 %
- ROCE 49.6 %
- ROE 36.3 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 71.3% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 39.3%
Cons
- Stock is trading at 31.6 times its book value
- Debtor days have increased from 54.0 to 76.0 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 106 | 94 | 136 | 146 | 204 | 324 | 469 | |
| 95 | 84 | 119 | 128 | 158 | 231 | 329 | |
| Operating Profit | 11 | 11 | 17 | 18 | 46 | 93 | 140 |
| OPM % | 10% | 11% | 13% | 12% | 23% | 29% | 30% |
| 0 | 1 | 1 | 1 | 2 | 6 | 7 | |
| Interest | 1 | 2 | 1 | 1 | 1 | 0 | 5 |
| Depreciation | 1 | 2 | 2 | 3 | 3 | 5 | 28 |
| Profit before tax | 8 | 8 | 14 | 15 | 45 | 94 | 113 |
| Tax % | 28% | 26% | 27% | 26% | 24% | 26% | 25% |
| 6 | 6 | 10 | 11 | 34 | 69 | 84 | |
| EPS in Rs | 66.67 | 63.67 | 93.55 | 1.24 | 2.71 | 5.57 | 6.80 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 8% | 17% | 16% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 38% |
| 3 Years: | 47% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 71% |
| 3 Years: | 99% |
| TTM: | 24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 241% |
| 1 Year: | 155% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 40% |
| 3 Years: | 39% |
| Last Year: | 36% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 0.10 | 10 | 14 | 25 | 25 |
| Reserves | 8 | 14 | 24 | 26 | 112 | 167 | 248 |
| 16 | 12 | 12 | 7 | 1 | 1 | 11 | |
| 12 | 12 | 13 | 18 | 24 | 28 | 45 | |
| Total Liabilities | 36 | 38 | 49 | 62 | 151 | 221 | 328 |
| 13 | 17 | 23 | 28 | 60 | 67 | 153 | |
| CWIP | 0 | 0 | 0 | 5 | 1 | 4 | 13 |
| Investments | 0 | 0 | 0 | 0 | 5 | 4 | 3 |
| 23 | 21 | 26 | 28 | 86 | 146 | 159 | |
| Total Assets | 36 | 38 | 49 | 62 | 151 | 221 | 328 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 1 | 12 | 18 | 17 | 17 | 37 | 69 | |
| -11 | -6 | -8 | -20 | -57 | -18 | -70 | |
| 7 | -5 | -2 | -5 | 48 | -3 | -1 | |
| Net Cash Flow | -2 | 1 | 8 | -7 | 8 | 15 | -2 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 15 | 17 | 9 | 22 | 40 | 46 | 76 |
| Inventory Days | 204 | 315 | 208 | 136 | 87 | 121 | 135 |
| Days Payable | 125 | 168 | 73 | 109 | 129 | 75 | 111 |
| Cash Conversion Cycle | 94 | 163 | 143 | 49 | -2 | 92 | 100 |
| Working Capital Days | -16 | -15 | -19 | -11 | 29 | 57 | 58 |
| ROCE % | 38% | 50% | 39% | 53% | 58% | 50% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6h - Investor group meeting on 04 Sep 2025 at Trident BKC; MD Manish Grover attending Ashwamedh-Elara India Dialogue.
-
Publication Of Case Studies
7h - 28 Aug 2025: Jeena Sikho Lifecare published four Ayurvedic case studies authored by MD and clinicians.
-
The Board At Its Meeting Held On 27Th August, 2025 Decided To Hold The 8Th Annual General Meeting Of The Company On Monday, 29Th September, 2025 At 12:00 Noon.
1d - Board approved ESOP (up to 250,000 options), COO appointment, director re-designation, AGM Sept 29, dividend record date Sept 22.
- Book Closure Of The Register Of Members And Share Transfer Books Of The Company From Tuesday September 23, 2025 To Monday September 29, 2025 (Both Days Inclusive) For The 8Th Annual General Meeting. 1d
-
Approval Of Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2025
1d - Board approved ESOP up to 250,000 options @Rs2; appointed COO Sahil Jain; final dividend ₹1.10; AGM Sep 29.
Annual reports
Concalls
-
Aug 2025Transcript PPT
-
Aug 2025TranscriptNotesPPT
-
Jul 2025TranscriptNotesPPTREC
-
May 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptNotesPPT REC
-
May 2024Transcript PPT
-
Feb 2024TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
Business Segment
a) Hospitals & Clinics Portfolio[1]
Jeena Sikho Lifecare Limited (JSLL) operates a network of 36 hospitals and 74 clinics/daycare centres across 21 states and 100+ cities in India. The hospitals have 1,530 operational beds, with another 518 beds in the pipeline.